Trial of Deferiprone in Parkinson’s Disease-Reference-Cited by-同舟云学术

Trial of Deferiprone in Parkinson’s Disease

Published:2022-12-01 Issue:22 Volume:387 Page:2045-2055
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Devos David¹,Labreuche Julien¹,Rascol Olivier¹,Corvol Jean-Christophe¹,Duhamel Alain¹,Guyon Delannoy Pauline¹,Poewe Werner¹,Compta Yaroslau¹,Pavese Nicola¹,Růžička Evžen¹,Dušek Petr¹,Post Bart¹,Bloem Bastiaan R.¹,Berg Daniela¹,Maetzler Walter¹,Otto Markus¹,Habert Marie-Odile¹,Lehericy Stéphane¹,Ferreira Joaquim¹,Dodel Richard¹,Tranchant Christine¹,Eusebio Alexandre¹,Thobois Stéphane¹,Marques Ana-Raquel¹,Meissner Wassilios G.¹,Ory-Magne Fabienne¹,Walter Uwe¹^ORCID,de Bie Rob M.A.¹,Gago Miguel¹,Vilas Dolores¹,Kulisevsky Jaime¹,Januario Cristina¹,Coelho Miguel V.S.¹,Behnke Stefanie¹,Worth Paul¹,Seppi Klaus¹,Ouk Thavarak¹,Potey Camille¹,Leclercq Céline¹,Viard Romain¹,Kuchcinski Gregory¹,Lopes Renaud¹,Pruvo Jean-Pierre¹,Pigny Pascal¹,Garçon Guillaume¹,Simonin Ophélie¹,Carpentier Jessica¹,Rolland Anne-Sophie¹,Nyholm Dag¹,Scherfler Christoph¹,Mangin Jean-François¹,Chupin Marie¹,Bordet Régis¹,Dexter David T.¹,Fradette Caroline¹,Spino Michael¹^ORCID,Tricta Fernando¹,Ayton Scott¹^ORCID,Bush Ashley I.¹,Devedjian Jean-Christophe¹,Duce James A.¹,Cabantchik Ioav¹,Defebvre Luc¹,Deplanque Dominique¹^ORCID,Moreau Caroline¹

Affiliation:

1. From the Departments of Medical Pharmacology (D. Devos, A.-S.R., R.B., J.-C.D.), Neuroradiology (R.V., G.K., R.L., J.-P.P.), and Neurology (L.D., C.M.), University of Lille, Lille Neuroscience and Cognition, Team DVCD, INSERM Unité Mixte de Recherche Scientifique (UMRS) 1172, Centre Hospitalier Universitaire (CHU) de Lille, Expert Center of Parkinson’s Disease, Lille Center of Excellence for Neurodegenerative Disorders (LiCEND) Network of Centers of Excellence in Neurodegeneration (CoEN) Center, NS...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2209254

Reference25 articles.

1. The burden of Parkinson's disease: a worldwide perspective

2. The role of iron in brain ageing and neurodegenerative disorders

3. Iron as a therapeutic target for Parkinson's disease

4. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

5. Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s Disease;International Encyclopedia of Public Health;2025

2. Ferroptosis in Parkinson's disease —— The iron-related degenerative disease;Ageing Research Reviews;2024-11

3. The role of metal ions in stroke: Current evidence and future perspectives;Ageing Research Reviews;2024-11

4. Acteoside alleviates lipid peroxidation by enhancing Nrf2-mediated mitophagy to inhibit ferroptosis for neuroprotection in Parkinson's disease;Free Radical Biology and Medicine;2024-10

5. The role of iron transporters and regulators in Alzheimer’s disease and Parkinson’s disease: Pathophysiological insights and therapeutic prospects;Biomedicine & Pharmacotherapy;2024-10